catheter-related bladder discomfort (CRBD)
Conditions
Interventions
Flurbiprofen group:Intravenous injection of flurbiprofen axetil 50mg
Control group:Intravenous injection of the same volume saline
Sponsors
Mianyang Central Hospital
Eligibility
Sex/Gender
All
Age
60 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 60 ~ 80 years; 2. American Society of Anesthesiologists (ASA) grade I to III; 3. Plan to undergo transurethral resection of the prostate; 4. Body mass index (BMI) between 18 and 30kg/m^2; 5. The subjects give informed consent before the experiment and sign the informed consent voluntarily.
Exclusion criteria
Exclusion criteria: 1. Severe kidney disease, heart disease, lung disease and liver disease; 2. Chronic pain patients; 3. Long-term use of painkillers; 4. Cognitive dysfunction, neuropsychiatric diseases; 5. Allergic to the tested drug; 6. Previous bladder diseases (overactive bladder, obstruction of bladder outflow tract, etc.); 7. Patients with a history of gastrointestinal bleeding or perforation after previous use of NSAIDs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of catheter-related bladder discomfort above a moderate grade; | — |
Secondary
| Measure | Time frame |
|---|---|
| Apioid consumption;The incidence of catheter-related bladder discomfort above a moderate grade;Numeric rating scale (NRS);Patient satisfaction; | — |
Countries
China
Contacts
Public ContactZhang Yonghong
Mianyang Central Hospital
Outcome results
None listed